Arthneeti
All Q1 FY26 results →
TC

The Cooper Companies, Inc.

Q1 FY26Health Care Equipment and Supplies

The Cooper Companies, Inc. Q1 FY26 Results — Earnings Call Analysis

Q1 FY26 earnings call: what management said on revenue, margins and capex.

Price₹61
Market cap₹11.9K Cr
P/E30.9
Updated30 May 2026
Read4 min read

The Cooper Companies, Inc. Q1 FY26 key numbers

Revenue
CooperVision revenue expected at $2.9 billion to $2.93 billion, up 4.5% to 5.5% organically.

As stated in The Cooper Companies, Inc.'s Q1 FY26 earnings call transcript · published 30 May 2026. Reported figures, not investment advice.

The short version

- Fiscal 2026 revenue guidance is $4.3 billion to $4.35 billion, reflecting organic growth of 4.5% to 5.5%. - Q1 earnings exceeded guidance top end, with non-GAAP EPS up 20% to $1.10.

From The Cooper Companies, Inc.'s Q1 FY26 earnings-call transcript · updated 30 May 2026.

Revenue & Sales Performance

Slow growth
  • Fiscal 2026 revenue guidance is $4.3 billion to $4.35 billion, reflecting organic growth of 4.5% to 5.5%.
  • CooperVision revenue expected at $2.9 billion to $2.93 billion, up 4.5% to 5.5% organically.
  • CooperSurgical revenue projected at $1.4 billion to $1.41 billion, organic growth of 4% to 5%.
  • Asia Pacific expected to remain down in Q2 due to declining legacy hydrogel sales but projected to return to growth in Q3 with new product launches and private label contracts.
  • Strong momentum in Americas and EMEA with ongoing product launches, contract wins, and improved visibility for growth.
  • MiSight contact lenses, MyDay multifocal, Energys, and toric multifocal products are key growth drivers.

2 more points from The Cooper Companies, Inc.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what The Cooper Companies, Inc. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • The multiyear CapEx cycle is winding down, with early planning underway for next-generation production improvements.
  • Manufacturing teams are evaluating ways to capitalize on the production advancements developed over the past several years.
  • These next-generation manufacturing investments are expected to be material but will take time to realize.
  • CapEx guidance reflects a decline, contributing to improved free cash flow expectations.
  • The company is investing in growth and innovation, with a focus on leveraging technology including AI to optimize operations.

2 more points from The Cooper Companies, Inc.'s call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what The Cooper Companies, Inc. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Some relevant related points include: - The company has won a number of new contracts in all three regions, particularly related to MyDay products, indicating a growing backlog of business. - Execution on private label contracts and branded contracts is ongoing and expected to support sustainable growth into the middle and back half of the year. - They have good visibility on contract wins that are expected to result in improved performance in Q2 and beyond.

What the Q1 FY26 call signalled

1 of 3 strong

RevenueSlow growth
MarginMargins steady
CapexCapex planned

Continue your research

Others in Health Care Equipment and Supplies this season

  • Medtronic plc (Q1 FY26)

    Medtronic plc Q1 FY26 quarterly results analysis. Renal denervation (RDN) shows strong consumer demand with visits jumping from 50,000 in Q2 to 2.5 million in Q

Compare:vs Intuitive Surgical, Inc.vs Stryker Corporationvs Medtronic plc

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

The Cooper Companies, Inc. and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were The Cooper Companies, Inc. Q1 FY26 results?

- Fiscal 2026 revenue guidance is $4.3 billion to $4.35 billion, reflecting organic growth of 4.5% to 5.5%. - Q1 earnings exceeded guidance top end, with non-GAAP EPS up 20% to $1.10.

What is The Cooper Companies, Inc. share price analysis?

The Cooper Companies, Inc. currently shows a neutral. The stock trades at a P/E of 30.9 with a market cap of $11,910. Investors should review the full earnings analysis for detailed insights.

Is The Cooper Companies, Inc. planning capital expenditure?

- The multiyear CapEx cycle is winding down, with early planning underway for next-generation production improvements.

Keep The Cooper Companies, Inc. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.